Global gamma-Valerolactone (CAS 108-29-2) Market Outlook 2019-2024

March 2019 | 130 pages | ID: GAF2A590DD6EN
Gen Consulting Company

Abstracts

The 'Global gamma-Valerolactone (CAS 108-29-2) Market Outlook 2019-2024' offers detailed coverage of gamma-valerolactone industry and presents main market trends. The market research gives historical and forecast market size, demand, end-use details, price trends, and company shares of the leading gamma-valerolactone producers to provide exhaustive coverage of the market for gamma-valerolactone. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography.

The report has been prepared based on an in-depth market analysis with inputs from key industry participants. The global gamma-valerolactone market has been segmented into five major regions, namely, North America (U.S., Canada, and others), Europe (U.K., France, Germany, Russia, and others), Asia-Pacific (China, Japan, India, Australia, and others), South America (Brazil, Argentina, and others), and Middle East & Africa (South Africa, Saudi Arabia, and others). Furthermore, the report also includes an in-depth competitive analysis of the key vendors operating in this market.

Key Regions

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America

Key Vendors

• Anhui Hyea Aromas Co., Ltd.
• Inoue Perfumery MFG. Co., Ltd.
• Jiangsu Qingquan Chemical Co., Ltd.
• MYJ Chemical Co., Ltd.
• request free sample to get a complete list of companies

Key Questions Answered in This Report

• Analysis of the gamma-valerolactone market including revenues, future growth, market outlook
• Historical data and forecast
• Regional analysis including growth estimates
• Analyzes the end user markets including growth estimates.
• Profiles on gamma-valerolactone vendors including products, sales/revenues, SWOT, and market position, recent developments.
• Market structure, market drivers and restraints.

Contents

PART 1. SUMMARY

PART 2. REPORT METHODOLOGY

2.1 Methodology
2.2 Data Source

PART 3. INTRODUCTION

PART 4. INDUSTRY VALUE CHAIN

4.1 gamma-Valerolactone Industry Value Chain Analysis
4.2 Upstream
4.3 End-uses
4.4 Distributors

PART 5. COMPETITIVE LANDSCAPE

5.1 Global gamma-Valerolactone Sales & Share by Company (2014-2019)
5.2 Global gamma-Valerolactone Revenue & Share by Company (2014-2019)
5.3 Pricing Trends
5.4 Competitive Trends

PART 6. SEGMENTATION BY TYPE

6.1 Global gamma-Valerolactone Sales Volume by Type (2014-2019)
6.2 Global gamma-Valerolactone Revenue by Type (2014-2019)
6.3 Global gamma-Valerolactone Price by Type (2014-2019)

PART 7. SEGMENTATION BY APPLICATION

7.1 Global gamma-Valerolactone Sales Volume by Application (2014-2019)
7.2 Global gamma-Valerolactone Revenue by Application (2014-2019)
7.3 Global gamma-Valerolactone Price by Application (2014-2019)

PART 8. REGIONAL PERSPECTIVES

8.1 Overview
8.2 North America
  8.2.1 Market Size (Volume & Value)
  8.2.2 by Application
  8.2.3 by Country (U.S., Canada, Mexico, etc.)
8.3 Europe
  8.3.1 Market Size (Volume & Value)
  8.3.2 by Application
  8.3.3 by Country (Germany, UK, France, Spain, Italy, etc.)
8.4 Asia-Pacific
  8.4.1 Market Size (Volume & Value)
  8.4.2 by Application
  8.4.3 by Country (China, Japan, Korea, India, etc.)
8.5 Middle East & Africa
  8.5.1 Market Size (Volume & Value)
  8.5.2 by Application
  8.5.3 by Country (Saudi Arabia, Turkey, Nigeria, Iran, South Africa, etc.)
8.6 South America
  8.6.1 Market Size (Volume & Value)
  8.6.2 by Application
  8.6.3 by Country (Brazil, Argentina, Colombia, etc.)

PART 9. COMPANY PROFILES

9.1 Company Profile
9.2 Product Offered
9.3 Business Performance
9.4 Recent Developments

PART 10. MARKET FORECAST

10.1 Global gamma-Valerolactone Market Size Forecast (2019-2024)
  10.1.1 Global gamma-Valerolactone Sales Forecast (2019-2024)
  10.1.2 Global gamma-Valerolactone Revenue Forecast (2019-2024)
10.2 Forecast by Region
  10.2.1 North America
  10.2.2 Europe
  10.2.3 Asia-Pacific
  10.2.4 Middle East & Africa
  10.2.5 South America
10.3 Forecast by Type
10.4 Forecast by Application

PART 11. MARKET DRIVERS

11.1 Opportunities
11.2 Challenges
11.3 Economic/Political Environmental

PART 12. INDUSTRY ACTIVITY

12.1 M&As, JVs and Partnership
12.2 Other Developments

PART 13. APPENDIX

DISCLAIMER
ABOUT GEN CONSULTING COMPANY